Cancer :: What cures your aches might prevent cancer
Mayo Clinic Cancer Center has begun three clinical studies looking at the use of nonsteroidal anti-inflammatory drugs (NSAIDs) to prevent cancer — colon, esophageal or lung.
Medical
Breast Cancer :: Second opinion yields treatment changes for half of patients
More than half of breast cancer patients who sought a second opinion from a multidisciplinary tumor board received a change in their recommended treatment plan, according to a new study from the University of Michigan Comprehensive Cancer Center.
HIV :: AIDS kills 250,000 people each month – like monthly tsunami
More people die from HIV/Aids every month than in the Indian Ocean tsunami, says Professor Robert Gallo, who helped identify the HIV/AIDS virus nearly 25 years ago, said the Asian tsunami killed an estimated 230,000 people.
Healthcare :: Shut nine New York hospitals to save billion
To control soaring medical costs, New York state must shut nine hospitals and reorganize another 48 centers to save $1.5 billion a year while also improving the quality of care, a reform commission proposed on Tuesday.
HIV :: Boehringer Ingelheim’s patent rights are no obstacle to access to ARV drugs in developing countries
On the occasion of World Aids Day 2006 Boehringer Ingelheim stated that its patent rights to Viramune (nevirapine) do not prevent access to this medication in low income countries.
Disinfectant :: Solvay’s Perestane effective against Clostridium difficile and MRSA
Perestane?, an innovative biocidal product created and developed by Solvay, has been proven to be an effective disinfectant against Methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile. These so-called ?superbugs? may cause fatal diseases, and the treatment of patients with most current antibiotics is ineffective. Researchers from the University of Leeds and Leeds General Infirmary (United Kingdom) have recently demonstrated that disinfectants commonly used in hospitals fail to eradicate Clostridium difficile from the premises, and may even promote spore formation.
Sclerosis :: First international gene screen for typical ALS is on track
The largest-scale search for genes that underlie sporadic amyotrophic lateral sclerosis (ALS), the most common form of the disease, has crossed its first hurdle with the successful compiling of genetic information on more than 1,000 patients and controls.
Rheumatoid Arthritis :: Impact of immunosuppressive medications on cardiovascular events in RA patients
Researchers at Harvard Medical School’s Brigham and Women’s Hospital compared the effects of a variety of immunosuppressive agents on cardiovascular events in a large sample of RA patients.
Arthritis :: New therapeutic hope for degenerative disc disease
For some domestic mammals, including sheep, goats and dogs, the occurrence of degenerative disc disease is extremely rare. Intrigued by this fact and how it might apply to humans, researchers in Toronto, Canada, decided to conduct a gene expression study on intervertebral discs from canines.
Healthcare :: Novartis highlights strong R&D pipeline, plans for multiple new product launches
Novartis unveiled today new data on its promising pipeline amid plans for multiple new product approvals and launches over the next two years. Many of these anticipated approvals are for potentially best-in-class medicines that would advance treatment standards for patients with hypertension, diabetes, cancer and other diseases.